Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03489837
NCT03489837
Completed
Phase 3

A Randomized, Double-blind, Multicenter, Active-controlled Phase III Study to Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

Hyundai Pharm1 site in 1 country272 target enrollmentJanuary 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEvaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
InterventionsLevotuss

Overview

Phase
Phase 3
Intervention
Levotuss
Conditions
Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Sponsor
Hyundai Pharm
Enrollment
272
Locations
1
Primary Endpoint
Cough severity check
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

A randomized, double-blind, multicenter, active-controlled phase III study to evaluate the efficacy and safety of Levotuss CR tab. in comparison with Levotuss syrup in patients with cough due to acute or chronic bronchitis

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
October 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hyundai Pharm
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •moderate, severe, very severe non-productive cough patients

Exclusion Criteria

  • •Patients receiving a concomitant therapy

Arms & Interventions

Levotuss CR tab

oral taken

Intervention: Levotuss

Levotuss syrup

oral taken

Intervention: Levotuss

Outcomes

Primary Outcomes

Cough severity check

Time Frame: 6 hours

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients with Gastric UlcerGastric Ulcer
NCT05656092Hanmi Pharmaceutical Company Limited199
Recruiting
Phase 3
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis PatientsRifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
NCT05824871Shanghai Jiatan Pharmatech Co., Ltd450
Unknown
Phase 3
BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's DiseaseModerate-to-severe Alzheimer's Disease
NCT04229927Hyundai Pharmaceutical Co., LTD.712
Completed
Phase 3
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With OsteoporosisPostmenopausal Women With Osteoporosis
NCT01581320Alvogen Korea201
Completed
Phase 3
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 TrialGlabellar Lines
NCT05804656CKD Bio Corporation300